LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

27.01 -2.14

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

26.68

Max

27.18

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-28M 22M
Pardavimai	4.3M 244M
P/E Sektoriaus vid.	10.185 57.05
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	9.224
Darbuotojai	293
EBITDA	-22M 52M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+49.46% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	49M 1.6B
Ankstesnė atidarymo kaina	29.15
Ankstesnė uždarymo kaina	27.01

Naujienos nuotaikos

By Acuity

50%

171 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-24 18:58; UTC

Pagrindinės rinkos jėgos

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

2026-03-24 23:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

2026-03-24 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Rises, Boosted by Dollar Weakness -- Market Talk

2026-03-24 23:16; UTC

Rinkos pokalbiai

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

2026-03-24 22:40; UTC

Uždarbis

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

2026-03-24 21:44; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-03-24 21:44; UTC

Rinkos pokalbiai

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

2026-03-24 20:59; UTC

Uždarbis

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

2026-03-24 20:58; UTC

Svarbiausios naujienos

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

2026-03-24 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Energy & Utilities Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-24 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-24 20:25; UTC

Uždarbis

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

2026-03-24 20:15; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Commodities Roundup: Market Talk

2026-03-24 20:10; UTC

Rinkos pokalbiai

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Sales $378.7M >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q Adj EPS 98c >WOR

2026-03-24 20:10; UTC

Uždarbis

Worthington Enterprises 3Q EPS 92c >WOR

2026-03-24 19:25; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

2026-03-24 19:06; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

2026-03-24 18:51; UTC

Rinkos pokalbiai

Svarbiausios naujienos

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-03-24 18:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

2026-03-24 18:34; UTC

Svarbiausios naujienos

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

2026-03-24 18:27; UTC

Rinkos pokalbiai

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

2026-03-24 18:21; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Silver Snaps 9-Session Losing Streak -- Market Talk

2026-03-24 18:00; UTC

Įsigijimai, susijungimai, perėmimai

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

49.46% į viršų

12 mėnesių prognozė

Vidutinis 41.25 USD 49.46%

Aukščiausias 62 USD

Žemiausias 25 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

171 / 350 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.